Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sheffield Bio-Science, a Kerry Group Business, has agreed to become the exclusive global sales and distribution partner for recombinant insulin manufactured by global Indian biotech Wockhardt.
Subscribe to our email newsletter
Reportedly, Wockhardt was the first in Asia and only the fourth company in the world to have developed, manufactured and marketed Wosulin, recombinant insulin injectables.
As a result of this strategic alliance customers will now have greater access to the cell culture media ingredient-technologies, including recombinant proteins, chemically defined metabolic enhancers, hydrolyzed proteins, and yeast extracts.
Such high quality solutions make it easier for biopharmaceutical manufacturers to delay apoptosis and maximize product yields.
Wockhardt Group chairman Habil Khorakiwala said the partnership is a reaffirmation of Wockhardt’s biotechnology research prowess and a confluence of innovative novel technology now being offered to global cell culture markets.
Sheffield Bio-Science president Edmond Scanlon said the strategic alliance marks another step in their continued investment to strengthen cell culture media supplement portfolio.
Wockhardt has 5 research centers and 21 manufacturing plants in India, USA, UK, France and Ireland.